Medtronic Receives FDA Clearance for New InPen App
Medtronic has secured FDA clearance for its updated InPen app, a significant step forward in diabetes management. The latest app introduces missed meal dose detection, a key feature that paves the way for Medtronic’s upcoming Smart MDI system. This system integrates the InPen smart insulin pen with the Simplera continuous glucose monitor (CGM), providing real-time, personalised insights for individuals managing diabetes through multiple daily injections (MDI).
The Smart MDI system aims to reduce the guesswork in diabetes management, offering proactive dosing advice tailored to individual needs. Medtronic plans a phased release, starting with existing standalone CGM and InPen users, followed by a broader commercial rollout.
This development demonstrates Medtronic’s commitment to simplifying diabetes care through cutting-edge technology and empowering patients to better manage their health.
Read the full article on Med-Tech News: Medtronic Receives FDA Clearance for New InPen App
Credit: Med-Tech News
____________________________________________________________________________________________________________________________________________________________________________________________________
Cure Talent is a recruitment agency dedicated to the medical technology industry. Whether you are looking for a new role in the medical device sector or you’re an innovative medical device, digital health, or biotech company looking for staff, get in touch with the team today and explore how Cure Talent can help!